Avidity Partners Management LP Immunocore Holdings PLC Transaction History

Avidity Partners Management LP

$2.03 Billion
Q2 2024

A detailed history of Avidity Partners Management LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Avidity Partners Management LP holds 200,000 shares of IMCR stock, worth $6.67 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

200,000

Previous 286,400 30.17%

Holding current value

$6.67 Million

Previous $18.6 Million 63.59%

% of portfolio

0.33%

Previous 0.72%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$33.78 - $63.75 $2.92 Million - $5.51 Million	-86,400 Reduced 30.17%	200,000 $6.78 Million
Q1 2024 May 15, 2024	SELL	$60.14 - $75.36 $829,932 - $1.04 Million	-13,800 Reduced 4.6%	286,400 $18.6 Million
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $2.06 Million - $3.34 Million	-48,000 Reduced 13.79%	300,200 $20.5 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $11.2 Million - $15.1 Million	-226,800 Reduced 39.44%	348,200 $18.1 Million
Q2 2023 Aug 14, 2023	SELL	$48.54 - $61.64 $9.46 Million - $12 Million	-194,800 Reduced 25.31%	575,000 $34.5 Million
Q1 2023 May 15, 2023	SELL	$46.12 - $65.71 $17.7 Million - $25.2 Million	-384,200 Reduced 33.29%	769,800 $38.1 Million
Q4 2022 Feb 14, 2023	SELL	$45.51 - $65.08 $42.1 Million - $60.2 Million	-925,100 Reduced 44.5%	1,154,000 $65.9 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $27.2 Million - $41.9 Million	729,100 Added 54.01%	2,079,100 $97.6 Million
Q2 2022 Aug 15, 2022	SELL	$25.46 - $37.72 $351,348 - $520,536	-13,800 Reduced 1.01%	1,350,000 $50.4 Million
Q1 2022 May 16, 2022	BUY	$18.94 - $34.29 $2.53 Million - $4.59 Million	133,800 Added 10.88%	1,363,800 $40.8 Million
Q4 2021 Feb 14, 2022	BUY	$27.58 - $40.0 $3.71 Million - $5.38 Million	134,400 Added 12.27%	1,230,000 $42.1 Million
Q3 2021 Nov 15, 2021	BUY	$27.98 - $40.0 $13.8 Million - $19.8 Million	494,600 Added 82.3%	1,095,600 $40.6 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $41.5 $1.64 Million - $2.12 Million	51,000 Added 9.27%	601,000 $23.5 Million
Q1 2021 May 17, 2021	BUY	$36.3 - $56.34 $20 Million - $31 Million	550,000 New	550,000 $23.4 Million

Others Institutions Holding IMCR

# of Institutions

151

Shares Held

39.6M

Call Options Held

157K

Put Options Held

135K

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.46B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Immunocore Holdings PLC Transaction History